Drug approval: Crizotinib for relapsed or refractory, ALK-positive, systemic anaplastic large cell lymphoma in pediatrics
Bulletin du cancer（2023）
关键词
Anaplastic large cell lymphoma,Crizotinib,Tyrosine kinase inhibitor,ALK
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要